Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mainstreaming Genetic Testing for Non-Ischemic Cardiomyopathy in Western Canada: A Family-Centered and Genome-First Approach to a Common and Life-Threatening Cardiomyopathy

NCT07345338 is registered in ClinicalTrials.gov with Thomas Roston as lead sponsor.

NCT NCT07345338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07345338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mainstreaming Genetic Testing for Non-Ischemic Cardiomyopathy in Western Canada: A Family-Centered and Genome-First Approach to a Common and Life-Threatening Cardiomyopathy
Lead sponsor
Thomas Roston
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
February 2, 2026
Completion date
March 31, 2027
Enrollment
300 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

dilated cardiomyopathy (dcm), nonischemic cardiomyopathy